Loading clinical trials...
Loading clinical trials...
A Phase I Study of a Gamma Secretase Inhibitor for Adult and Pediatric Patients With Relapsed or Refractory Acute T-Cell Lymphoblastic Leukemia and Lymphoma
Conditions
Interventions
MK0752, (Notch Inhibitor)
Start Date
February 1, 2005
Primary Completion Date
September 1, 2006
Completion Date
October 1, 2006
Last Updated
May 27, 2015
NCT05006716
NCT07277231
NCT06859424
NCT01804686
NCT05254743
NCT05371808
Lead Sponsor
Merck Sharp & Dohme LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions